From October 1, 2022 to December 31, 2022, the company has repurchased 5,409,000 shares, representing 0.49% for CNY 45.67 million. With this, the company has completed the repurchase of 33,001,600 shares, representing 2.97% for CNY 289.98 million under the buyback announced on April 8, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.27 CNY | +0.83% |
|
-0.14% | -32.50% |
18/06 | Jinyu Bio-Technology's Unit Gets Nod to Produce Triple Cat Vaccine | MT |
28/05 | China Issues Temporary Approval for Jinyu's Inactivated Bovine Nodular Dermatosis Vaccine | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.50% | 1.12B | |
-11.05% | 78.75B | |
-5.74% | 6.97B | |
+25.38% | 3.7B | |
-7.93% | 3.03B | |
+11.82% | 1.66B | |
-35.50% | 1.07B | |
-28.56% | 931M | |
-14.58% | 891M | |
-6.09% | 880M |
- Stock Market
- Equities
- 600201 Stock
- News Jinyu Bio-technology Co., Ltd.
- Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022.